Nikko Asset Management Americas, Inc. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$157,263,029
-20.7%
3,465,470
-1.9%
1.88%
-10.0%
Q2 2023$198,327,328
+11.0%
3,533,357
-11.0%
2.09%
+1.4%
Q1 2023$178,746,255
+9.8%
3,972,139
-0.9%
2.06%
-12.2%
Q4 2022$162,863,249
-41.2%
4,006,476
-6.0%
2.35%
-33.7%
Q3 2022$277,078,000
+0.4%
4,262,736
-7.0%
3.54%
+3.8%
Q2 2022$276,054,000
-5.2%
4,584,098
-0.8%
3.41%
+59.5%
Q1 2022$291,044,000
-11.9%
4,619,747
+7.0%
2.14%
+23.0%
Q4 2021$330,526,000
-10.3%
4,319,471
+31.3%
1.74%
+9.9%
Q3 2021$368,426,000
-32.8%
3,289,516
-2.8%
1.58%
-26.3%
Q2 2021$548,120,000
+22.9%
3,383,456
-7.6%
2.15%
-1.8%
Q1 2021$445,955,000
-24.1%
3,659,865
-4.6%
2.18%
-34.5%
Q4 2020$587,456,000
+90.3%
3,836,823
+3.8%
3.34%
+21.9%
Q3 2020$308,755,000
+14.7%
3,697,667
-0.4%
2.74%
-22.4%
Q2 2020$269,118,000
-15.8%
3,711,970
-50.7%
3.53%
+17.7%
Q1 2020$319,478,000
+72.0%
7,533,082
+147.0%
3.00%
+2.4%
Q4 2019$185,733,000
+63.1%
3,049,553
+9.8%
2.92%
+44.6%
Q3 2019$113,846,000
+29.2%
2,777,414
+48.4%
2.02%
+17.0%
Q2 2019$88,143,000
+459.5%
1,871,408
+324.3%
1.73%
+316.6%
Q1 2019$15,754,000
+60492.3%
441,044
+47632.0%
0.42%
+41400.0%
Q4 2018$26,000
-48.0%
924
-17.8%
0.00%0.0%
Q3 2018$50,0001,1240.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders